Pernix Web Page Draws Untitled Letter for Questionable Product Claims

Drug Industry Daily
A A
Pernix Therapeutics’ promotional webpage for its bronchitis drug Cedax has drawn an untitled letter from the FDA for making misleading claims and omitting risk information.

To View This Article:

Login

Subscribe To Drug Industry Daily